No Data
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?QuantumScape Corporation (NYSE:QS) stock jumped 64.34% after the company announced it entered into an
Kymera Therapeutics Price Target Maintained With a $52.00/Share by Oppenheimer
Kymera Therapeutics Price Target Maintained With a $52.00/Share by
Express News | Oppenheimer Maintains Outperform on Kymera Therapeutics, Maintains $52 Price Target
Kymera Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/10/2024 45.15% Oppenheimer $52 → $52 Maintains Outperform 07/09/2024 0.49% B. Riley Securities $31 → $3
Kymera Therapeutics (KYMR) Surges 23.4%: Is This an Indication of Further Gains?
Kymera Therapeutics(KYMR.US) Director Sells US$17.35 Million in Common Stock
$Kymera Therapeutics(KYMR.US)$ Director Booth Bruce sold 453.96K shares of common stock on Jul 9, 2024 at an average price of $38.21 for a total value of $17.35 million.Source: Announcement What is